| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |